Find Out What Are The Important Factors To Raise The Biosurgery Market In Near Future 2022 - 2026
                     Biosurger
y  
Market
oAf 5t .7a% CAGR
The report "Biosurgery Market by The prominent players in this market  
 Product Type (Sealants,  are Johnson & Johnson (US), Baxter  
Hemostats, Adhesion Barrier,  International Inc. (US), Medtronic Plc  
Soft Tissue Attachments,  (Ireland), Becton, Dickinson & Co. (US),
Biological Meshes, DBM, Bone  B. Braun Melsungen AG (Germany),  
Stryker Corp. (US), Integra  
Graft Substitutes), Application
Lifesciences Holdings Corp. (US), CSL  
(Orthopedic, Cardiovascular), End Ltd. (Australia), Hemostasis LLC. (US),  
 User (Hospitals, Clinics) -  Global  Pfizer Inc. (US), Cyrolife Inc. (US),  
Forecast to 2026", is projected to Zimmer Biomet (US), Kuros Biosciences 
 reach USD 16.0 billion by 2026   AG (Switzerland), Orthofix Medical Inc. 
from USD 12.2 billion in 2021, at a   (US), and Smiths & Nephew Plc. (UK).
CAGR of 5.7% during the forecast 
 period.
Johnson & Johnson (US) held the leading position in the biosurgery market in  
2020. The company offers a wide range of biosurgery products including bone  
graft substitutes, soft tissue attachments, hemostats, staple line reinforcement  
agents, and surgical sealants and adhesives. The company has a strong  
geographic presence established through its manufacturing and distribution  
facilities, across the globe. The company leverages its research capabilities and  
innovative product portfolio to ensure a leading position in the biosurgery market. 
 I n  FY2020, company invested about USD 12.2 Billion in R&D, out of which about 
 USD 2.1 billion were invested in Medical Devices business segment, an increase 
of  9.8% in comparison to FY2019.
Medtronic Plc (Ireland) held the second position in the global biosurgery market.  
Company has exhaustive product portfolio, specifically in bone graft substitutes  
and soft tissue attachment category. Additionally, the company leverages its  
research capabilities and innovative product portfolio to ensure a leading position 
 in the biosurgery market. I n  FY2020, the company invested USD 2,331 million in 
 R&D, up from USD 2253 million in FY2018. Medtronic focuses on organic growth 
 strategies such as innovation, product launch and approval for its growth in the  
biosurgery market, as evidenced by its recent product approval and launches  
during FY2018 to FY2019 across orthopedic and spine surgery portfolio.
The surgical sealants and adhesives 
 segment is expected to grow at the 
 highest CAGR
The orthopedic segment accounted for 
 the largest share
Hospitals segment accounted for the 
 largest share
Asia Pacific is expected to show the 
 highest growth rate
 Facebook
MarketsandMarkets™ INC. 
 About Us
 LinkedIn
MarketsandMarkets™ provides quantif ied 
 Twitter
 B2B research on 30,000  high growth  
niche  opportunit ies/threats which will 
impact  70% to 80% of worldwide 630 Dundee Road
companies’  revenues. Currently servicing Suite 430
7500   customers worldwide including Northbrook, IL 60062
USA : 1-888-600-6441
80% of  global Fortune 1000 companies 
as clients.  Almost 75,000 top off icers sales@marketsandmarket
across eight  industries worldwide   
approach  MarketsandMarkets™ for their s.com
painpoints  around revenues decisions.